Orezone Reports Q2-2025 Production and Hard Rock Expansion Update 
Malaysia and France Strengthen Defence Industry Ties with Landmark MoU Signing Baker McKenzie Adds Former Manhattan District Attorney Cyrus R. Vance Jr. as a Partner in New York
Former Manhattan District Attorney brings 30+ years of experience in white collar criminal investigations; will…
Advanced Energy to Announce Fourth Quarter and Full Year 2021 Results on February 9
DENVER–(BUSINESS WIRE)–Advanced Energy (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement,…
Velodyne Lidar Announces Dr. Anurag Gupta as Executive Vice President of Engineering
Dr. Gupta Leads Velodyne’s World-Class Engineering Team in Advancing Robust Portfolio of Lidar Hardware and…
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
Plenity is designed to help people feel satisfied with smaller portions so they can eat…
TELUS International Will Release Fourth Quarter 2021 Results and Host an Investor Call on February 10
VANCOUVER, British Columbia–(BUSINESS WIRE)–TELUS International (NYSE and TSX: TIXT) will release its fourth quarter…
Joe Nunn Joins Academy Securities as Managing Director, Fixed Income Sales
NEW YORK–(BUSINESS WIRE)–Academy Securities, a registered broker-dealer, certified Disabled Veteran Business Enterprise (DVBE), and Minority…
Plenity® National Media Campaign Kicking Off Today Challenges Restrictive Dieting Norms
Plenity is designed to help people feel satisfied with smaller portions so they can eat…
Mark Carney Joins Macro Advisory Partners as Senior Counsellor
Former Governor of the Bank of England will deepen the Firm’s global advisory offering by…
NICE Actimize Honored for Best Anti-Money Laundering Solution by Regulation Asia’s Excellence Awards
NICE Actimize’s anti-money laundering solutions were cited for their ability to leverage data analytics, artificial…
Atkore Inc. Announces First Quarter 2022 Results
Net sales of $840.8 million, up 64.5% versus prior year Net income per diluted share…
Footprint Announces Champions of Change Speaker Lineup at Sustainability Summit
Company’s Fourth Annual Event Convenes Global Sustainability Leaders at Footprint Center in Phoenix GILBERT, Ariz.–(BUSINESS…
iGrafx Acquires Logpickr, Adding Next Generation Process Mining to its Business Process Management Portfolio
Acquisition brings patent-pending technology to speed process discovery, delivering faster results for operational excellence, digital…
Clearview AI’s Revolutionary Facial Recognition Platform Awarded U.S. Patent
Image gathering and matching capabilities earn Clearview AI first of its kind patent protection NEW…
Springboard and UMass Global Launch a Four-Program Technical Skills Online Learning Partnership
Springboard’s largest university partnership delivers mentor-led online educational bootcamps to help working adults SAN FRANCISCO–(BUSINESS…
Signature Bank and Brooklyn Legal Services Corporation A Collaborate to Provide Funding Through Federal Home Loan Bank of New York’s Small Business Recovery Grant Program
Ten New York City Small Businesses Each Receive $10,000 to Provide Relief from Impact of…
TradeStation Reports Results for Three and Nine Months Ended December 31, 2021
PLANTATION, Fla.–(BUSINESS WIRE)–TradeStation Group, Inc. (“TradeStation”), the parent company of award-winning self-clearing online brokerages for…
Vocera Awarded a Place on NHS Shared Business Services Framework
New NHS SBS framework provides access to market leading communication tools SAN JOSE, Calif.–(BUSINESS WIRE)–$VCRA…
Nuvias UC signs new agreement with Yealink for expansion into DACH (Germany, Austria, Switzerland)
31/01/2022 Cwmbran Building on successful collaboration with Yealink in the UK, Nuvias UC now offers…
FDA approves Roche’s Vabysmo, the first bispecific antibody for the eye, to treat two leading causes of vision loss
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular…
CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe asthma with type 2 inflammation
CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe…